Meet 92-year-old man with Rs 26,560 crore net worth, who visits office 6 days a week and is connected to Ram Charan-Upasana
Upasana Konidela is a successful entrepreneur and the wife of renowned Telugu superstar Ram Charan. She hails from one of India's most respected and influential families. Her grandfather, Dr. Prathap C. Reddy, is the visionary founder of Apollo Hospitals, the first corporate medical chain in India. He is also a cardiologist and has over 5,000 pharmacy outlets and nearly 300 primary care clinics. At 92, he visits the office six days a week and serves as a testament to sheer determination, passion, and perseverance.
Ram Charan's 92-year-old grandfather-in-law, Dr. Prathap C.Reddy Daily Routine
Ram Charan 's grandfather-in-law begins his day in the office sharp at 10 a.m. and logs out at 5 p.m. In 1983, Dr. Prathap established India's first corporate hospital. As a pioneer of a healthcare revolution in India, he transformed the country's medical landscape to provide world-class healthcare facilities and advanced treatments.
His daily routine is filled with enthusiasm and commitment. After witnessing people traveling abroad for medical emergencies and advanced facilities, he dreamt of establishing a hospital in the country itself. Undoubtedly, the trailblazer of the Apollo hospital is living his dream every day.
Upasana Konidela's Grandad, Dr. Prathap C.Reddy's Personal Profile
With an estimated net worth of 340 crore USD, i.e., Rs. 26,560 crore, he strives to make healthcare affordable and accessible to everyone. Upasana's grandad earned his MBBS from Stanley Medical College, Chennai. Later, he flew to the U.S to specialize in cardiology. In 1970, he was quite capable of settling overseas, but one letter from his father got him back to his roots.
In 1979, the death of a patient in India, due to a lack of medical facilities, left a lasting impact on Dr. Reddy. With a widespread diagnostic network, he laid the foundation of an expansive medical empire in India. Today, his hospitals in cities and towns are nothing short of lifelines to millions.
Dr. Prathap exemplifies the spirit of innovation and defines healthcare at its best. He proves that age is just a number, serving as an inspiration to the entire nation. His legacy has been passed from generation to generation, and he continues to craft the future healthcare services in India. Ram Charan's wife is also involved in the Apollo Hospitals group, serving as the Vice Chairman of Apollo Life and Chief Editor of B Positive magazine.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
2 hours ago
- New Indian Express
Telangana HC seeks explanation over delay in opening government hospital
HYDERABAD: The Telangana High Court on Wednesday pulled up the state government for the inordinate delay in making operational a fully constructed and equipped 100-bedded government hospital in Alampur, Jogulamba Gadwal district. The court directed the government to file its response within two weeks, explaining the reasons for not commencing regular medical services at the facility. A division bench comprising Acting Chief Justice Sujoy Paul and Justice Renuka Yara expressed serious concern over the continued inaction, questioning why the hospital - built at a cost of Rs 21 crore and completed in October 2023 - remains non-functional even 18 months after completion. During the hearing, Acting Chief Justice Sujoy Paul observed, 'A 100-bedded hospital has been constructed in Alampur, but the state government is not opening it, not providing staff, and the equipment remains unused.' The Bench directed the government counsel to obtain clear instructions from relevant departments on the reasons for the delay. The directive came in response to a Public Interest Litigation (PIL) filed by social activist and politician S Ramchandra Reddy, a resident of Ieeja in Jogulamba Gadwal district. The petitioner alleged that despite several representations to the authorities, the hospital has not been made functional, depriving the people of Alampur of basic medical services.
Indian Express
3 hours ago
- Indian Express
NEET UG 2025 Result: Getting a seat in India seems difficult? Here's how to choose the right medical college abroad
– Abhijit Zaveri With NEET UG 2025 results declared and 12,36,531 students clearing the exam, the limited availability of just 1.25 lakh MBBS seats in India is compelling many qualified candidates to explore alternative options — ranging from allied health science streams like dentistry, pharmacy, public health, and biotechnology to pursuing MBBS degrees abroad. Given the rising competition, limited government seats, and the high cost of private medical education in India, overseas medical education is no longer seen as a fallback, but a strategic choice. Countries like Russia, Georgia, the Philippines, and Hungary offer globally recognised programs that are often more affordable, provide international exposure, and follow curricula aligned with global standards – making them increasingly attractive for thousands of students each year. Timely planning is key, as aspiring students must begin applications, complete documentation, and prepare for visa processes by mid-summer. Importantly, a Supreme Court ruling from February 2025 and NMC (National Medical Commission) guidelines mandate that all students – whether studying in India or abroad – must qualify NEET-UG for admission into any medical program and to gain eligibility for practice in India. Key Factors in Choosing a Country, or University Affordability vs Quality: Private MBBS programs in India can cost upwards of Rs 60–80 lakh. In contrast, countries like Russia and Georgia offer tuition in the range of Rs 15–40 lakh for the full course duration. Monthly living expenses range from Rs 10,000 – Rs20,000, depending on the country. While affordability is a key factor for many families, it should not be the sole criterion. A lower fee structure may sometimes come at the cost of compromised academic standards or inadequate clinical training, both of which are crucial for a successful medical career. One reliable way to assess the quality of education offered by foreign institutions is by looking at the pass rates of the Foreign Medical Graduate Examination (FMGE), a mandatory licensure test in India for students who have earned their MBBS degrees overseas. The upcoming National Exit Test (NExT) will serve a similar purpose. High FMGE or NExT pass rates are a strong indicator of a university's academic rigour and how well it prepares students for medical practice in India. Ultimately, affordability must be weighed against long-term value – including educational quality, clinical exposure, and the ability to secure a medical licence upon returning home. Accreditation and Curriculum Compatibility: A critical aspect often overlooked is program recognition. Students must ensure that their chosen foreign university is approved by the NMC. With the impending transition from FMGE to NExT (National Exit Test) from 2024–25, aligning the curriculum with Indian licensure requirements is essential. Programs with strong clinical rotations, English-medium instruction, and hospital tie-ups tend to better prepare students for these assessments. Language, Culture, and Student Support: Even in English-taught programs, basic proficiency in the local language is crucial for everyday interactions, especially during clinical postings. For example, learning languages like Russian or Georgian can greatly enhance the clinical experience, allowing students to communicate more effectively with patients and healthcare staff. Additionally, quality-of-life factors such as climate, food, culture, and safety play a significant role in choosing a destination. Countries like Georgia offer milder climates and cultural proximity, making it an appealing option for many students. On the other hand, Russia's harsh winters might present challenges for those unaccustomed to extreme cold. These considerations are essential for making an informed decision about studying abroad. Licensing Outcomes and Pass Rates: Pass rates for exams like the FMGE and the upcoming NExT are strong indicators of a country's medical education quality. Georgian medical universities consistently report high FMGE success rates, ranging from 60% to 80% at leading institutions, compared to much lower rates in countries like China and Ukraine, where success often falls below 20%. These figures are important factors students should consider when choosing where to study Popular destinations: Pros and cons Russia: Russia has long been a popular choice for Indian students pursuing MBBS. The 6-year program, which includes an internship, is offered in both English and Russian, providing a unique opportunity to learn the local language. Tuition fees are affordable, ranging from Rs 3–5 lakh per year, with moderate living costs. The visa process is efficient, and many Russian universities collaborate with Indian agents, making it easier for students to navigate the application process. Russia also boasts excellent infrastructure and a sizable Indian community. However, it's important to note that FMGE pass rates typically range from 40–55%. Georgia: Georgia's 6-year MBBS programs, taught in English, are approved by both WHO and NMC. Tuition ranges from Rs 4 – 6 lakh per year, with hostel expenses between Rs 16,000 – Rs20,000 per month. Several universities report FMGE success rates above 60%, and the country is known for its welcoming environment, mild climate, and European lifestyle. Due to limited university options, students must apply by June–July for September intake. Philippines: Adopting a US-based system, medical education in the Philippines consists of a 2-year BS (pre-med) and a 4-year MD program. All courses are taught in English, and tuition is affordable (Rs 2.5 – 6 lakh per year). Living costs are comparable to India. The American-style curriculum is ideal for students planning to take USMLE or NExT. However, students must clear NMAT and hold a bachelor's degree, adding 2–3 years to their timeline. While NMC approval exists, FMGE eligibility has sparked debate—although recent data shows improved licensing outcomes for Philippine graduates. Other Countries: Hungary's leading institutions, such as Semmelweis and Debrecen, offer 6-year English-language MBBS programs with annual tuition around Rs 13–15 lakh. FMGE pass rates average about 50%. Slovakia's Comenius and Pavol Jozef Šafárik Universities charge Rs 8,80,000- Rs 10,27,000(€9,000–€10,500) annually, with living costs ranging from Rs 49,000- Rs 78,000(€500–€800) per month. Though FMGE data for Slovakia is limited, these universities meet NMC norms and are becoming increasingly popular among Indian students. Immediate Abroad vs gap year Once the NEET results are declared, students are required to choose whether to go abroad or take a year off. Applying as soon as the results of NEET are out means students are in line with the academic calendar abroad (applications in summer, visas in fall, and classes in winter). This way, students don't have their education slowed by unexpected events. However, quick decisions require preparedness in documentation, finances, and visa procedures. Reappearing for NEET offers candidates another opportunity to secure a government medical seat in India. During this period, students can also explore foreign institutions more thoroughly, learn a new language, and plan their finances. At the same time, taking a gap year can be both tough emotionally and academically. Delays in starting medical education may impact future practice timelines—a concern backed by studies that show delayed NEET success pushes career start dates further. –A hybrid approach can work well: Students who are NEET-eligible and do not secure seats could take advantage of approved foreign programs, so they don't waste time. Common Pitfalls and Best Practices –Skipping NEET: Any Indian student planning to pursue medical degree overseas is required to have NEET qualification. –Overlooking NMC Approval: Always verify that both the university and its medical program are officially recognised by the National Medical Commission (NMC) for eligibility to practice in India. –Basing Decisions Solely on Cost: Lower fees in a medical program might mean sacrificing either the infrastructure or clinical quality. Looking at the past performance of FMGE/NExT can give you a clear picture of long-term worth. –Ignoring Language and Culture Barriers: English-medium classes don't eliminate the need for daily communication in local languages. Cultural compatibility impacts comfort and success. –Trusting Unverified Agents: Trust the resources given by embassies, well-known education portals, and comments from your peers. –Missing Application or Visa Deadlines: Students should mark all important dates—NEET application (Feb–Mar), results (June), international college deadlines (July), visa approvals (August–September). –Underestimating Total Expenses: Apart from tuition, students are required to cover costs for housing, meals, insurance, traveling, and unexpected emergencies. Visa applications often require proof of funds. Pursuing medical studies in a foreign country can have a major impact when planned well. Student should realize that low price does not always show the entire picture and think about the degrees they'll earn, quality of the institution, and their own qualifications. Because of programs like NExT as well as new opportunities worldwide, Indian medical students have a wide range of options, but they are responsible for making smart, forward-looking choices. If students consider the details of tuition, how the curriculum matches their needs, the university's accreditation, the place to live, and the influence on their future, students can chart a path that not only leads to a degree, but also a successful and fulfilling medical career. (The author is the founder and director of Career Mosaic)
Time of India
4 hours ago
- Time of India
Chhattisgarh State Consumer Commission orders SBI Life to pay Rs 50 lakh to widow, rejects concealment claim
RAIPUR: The Chhattisgarh State Consumer Disputes Redressal Commission has directed SBI Life Insurance Company to pay Rs 50 lakh to Savitri Salam, whose husband's insurance claim was initially rejected. The Commission found that the insurer failed to conclusively prove concealment of pre-existing diseases by the deceased. Savitri Salam, a resident of Surdongar village in Keshkal tehsil, filed a complaint after her husband's health deteriorated, leading to his demise on 16 June 2021. She had sought a claim under a policy taken by her husband, but SBI Life Insurance rejected it, alleging that he had provided incorrect information about his pre-existing medical conditions and treatment in the proposal form. The insurance company argued before the District Consumer Commission that the insured suffered from diabetes and heart disease prior to taking the policy, and this was noted in his medical records from AIIMS, Raipur, as part of his medical history. Based on this, the claim was rejected due to misrepresentation of health information in the proposal form. The District Consumer Commission, Kanker, accepted Savitri Salam's complaint and directed the insurance company to pay the full claim amount within one month. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo SBI Life Insurance then challenged this order before the Chhattisgarh State Consumer Disputes Redressal Commission. During the appeal hearing, the bench of Justice Gautam Chourdiya, President, and Pramod Kumar Varma, Member, determined that the claim was rejected solely based on a note in the AIIMS, Raipur, medical record. No other medical records were presented to conclusively prove that the insured suffered from diabetes and heart disease before applying for the policy, had undergone any prior treatment, or was on continuous medication. The Commission observed there was no evidence to suggest that the insured was aware of these conditions when he submitted the proposal. The State Commission concluded that it was not appropriate to claim the insured intentionally concealed important facts about his pre-existing diseases in the proposal. The appeal was rejected, and SBI Life Insurance Company has been directed to pay Rs 50 lakh from the life insurance claim, after deducting the Rs 56,621 premium amount already refunded to Savitri Salam by the insurance company. This amount will also include 7% annual simple interest from the date the complaint was filed (27 December 2023).
